IL1RAP and autoimmune myocarditis: IL1RAP blockade with a monoclonal antibody, compared with placebo and IL1Ra, reduced inflammatory monocytes, T cells, neutrophils, and eosinophils in the heart in CVB3-mediated VMC, and preserved heart function on echocardiography in autoimmune myocarditis